Postdoctoral Associate position available in the Department of Chemical Biology in the Ernest Mario School of Pharmacy to study the role/mechanism of alternative splicing variants in cancer progression and therapy and to use antisense-based technology to induce expression of therapeutically desirable variants of RTKs (EGFR, MET, AXL and others).
Minimum Education and Experience:
Senior or junior candidates should have a recent Ph.D. with strong backgrounds and skills in molecular biology, RNA biology and/or cancer biology and relevant first-author publications,
Required Knowledge, Skills, and Abilities:
Strong backgrounds and skills in molecular biology, RNA biology and/or cancer biology and relevant first-author publications,
Posting Number: 20FA0468
Location: Busch (RU-New Brunswick)
Internal Number: 114720
About Rutgers University
Rutgers, The State University of New Jersey, is a leading national public research university and the state's preeminent, comprehensive public institution of higher education. Rutgers is dedicated to teaching that meets the highest standards of excellence; to conducting research that breaks new ground; and to turning knowledge into solutions for local, national, and global communities. As it was at our founding in 1766, the heart of our mission is preparing students to become productive members of society and good citizens of the world. Rutgers teaches across the full educational spectrum: preschool to precollege; undergraduate to graduate and postdoctoral; and continuing education for professional and personal advancement. Rutgers is New Jersey's land-grant institution and one of the nation's foremost research universities, and as such, we educate, make discoveries, serve as an engine of economic growth, and generate ideas for improving people's lives.